Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
2000 1
2004 1
2005 1
2006 1
2007 2
2008 2
2009 1
2010 5
2011 4
2012 9
2013 9
2014 4
2015 12
2016 10
2017 12
2018 16
2019 11
2020 23
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 30020446

119 results
Results by year
Filters applied: . Clear all
Page 1
Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus-infected Adults With CD4 Cell Counts <100/μL: A Systematic Review and Meta-analysis.
Temfack E, Bigna JJ, Luma HN, Spijker R, Meintjes G, Jarvis JN, Dromer F, Harrison T, Cohen JF, Lortholary O. Temfack E, et al. Clin Infect Dis. 2019 Feb 1;68(4):688-698. doi: 10.1093/cid/ciy567. Clin Infect Dis. 2019. PMID: 30020446 Free article.
The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis.
Li Y, Huang X, Chen H, Qin Y, Hou J, Li A, Wu H, Yan X, Chen Y. Li Y, et al. BMC Infect Dis. 2020 Jun 12;20(1):410. doi: 10.1186/s12879-020-05126-z. BMC Infect Dis. 2020. PMID: 32532212 Free PMC article.
Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
Meya DB, Manabe YC, Castelnuovo B, Cook BA, Elbireer AM, Kambugu A, Kamya MR, Bohjanen PR, Boulware DR. Meya DB, et al. Clin Infect Dis. 2010 Aug 15;51(4):448-55. doi: 10.1086/655143. Clin Infect Dis. 2010. PMID: 20597693 Free PMC article.
Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.
Meya DB, Kiragga AN, Nalintya E, Morawski BM, Rajasingham R, Park BJ, Mubiru A, Kaplan JE, Manabe YC, Boulware DR. Meya DB, et al. J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):182-189. doi: 10.1097/QAI.0000000000001894. J Acquir Immune Defic Syndr. 2019. PMID: 30399034 Free PMC article. Clinical Trial.
Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program.
Beyene T, Zewde AG, Balcha A, Hirpo B, Yitbarik T, Gebissa T, Rajasingham R, Boulware DR. Beyene T, et al. Clin Infect Dis. 2017 Nov 29;65(12):2126-2129. doi: 10.1093/cid/cix613. Clin Infect Dis. 2017. PMID: 29020172 Free PMC article. Clinical Trial.
High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.
Wake RM, Britz E, Sriruttan C, Rukasha I, Omar T, Spencer DC, Nel JS, Mashamaite S, Adelekan A, Chiller TM, Jarvis JN, Harrison TS, Govender NP. Wake RM, et al. Clin Infect Dis. 2018 Feb 10;66(5):686-692. doi: 10.1093/cid/cix872. Clin Infect Dis. 2018. PMID: 29028998 Free PMC article.
Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R, Meya DB, Greene GS, Jordan A, Nakawuka M, Chiller TM, Boulware DR, Larson BA. Rajasingham R, et al. PLoS One. 2019 Jan 10;14(1):e0210105. doi: 10.1371/journal.pone.0210105. eCollection 2019. PLoS One. 2019. PMID: 30629619 Free PMC article.
A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda.
Nalintya E, Meya DB, Lofgren S, Huppler Hullsiek K, Boulware DR, Rajasingham R. Nalintya E, et al. J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):231-238. doi: 10.1097/QAI.0000000000001669. J Acquir Immune Defic Syndr. 2018. PMID: 29509588 Free PMC article.
Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
Frola C, Guelfand L, Blugerman G, Szyld E, Kaufman S, Cahn P, Sued O, Pérez H. Frola C, et al. PLoS One. 2017 Jun 15;12(6):e0178721. doi: 10.1371/journal.pone.0178721. eCollection 2017. PLoS One. 2017. PMID: 28617817 Free PMC article.
Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil.
Borges MASB, de Araújo Filho JA, Oliveira BJS, Moreira IS, de Paula VV, de Bastos AL, Soares RBA, Turchi MD. Borges MASB, et al. PLoS One. 2019 Jul 25;14(7):e0219928. doi: 10.1371/journal.pone.0219928. eCollection 2019. PLoS One. 2019. PMID: 31344140 Free PMC article.
119 results
Jump to page